Safe switch to beta-interferon treatment of chronic hepatitis C after alpha-interferon-induced autoimmune thrombocytopenia.
Tappero
G
G
Negro
F
F
Farina
M
M
Gallo
M
M
Angeli
A
A
Hadengue
A
A
D001327:Autoimmune Diseases / Q000209:etiology*; D002908:Chronic Disease; D005260:Female; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use*; D019233:Retreatment; D013921:Thrombocytopenia / Q000209:etiology*
D016898:Interferon-alpha; D016899:Interferon-beta